Skip to main content Skip to footer
Investor Relations
Back to OpusGTX.com
Opus Genetics, Inc. IR Overview
  • Overview
  • Press Releases
  • Events
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote and Chart
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Investor Tools
    • Email Alerts
    • Contacts
    • RSS News Feed
  • Back to OpusGTX.com

Press Releases

Sep 12, 2022 8:00 am EDT
Ocuphire Pharma Receives PDFUA Fee Waiver for Nyxol New Drug Application from FDA
Sep 8, 2022 8:00 am EDT
Ocuphire Pharma Announces Last Patient Completes Final Visit in ZETA-1 Phase 2b 24-Week Trial of Oral APX3330 in Diabetic Retinopathy
Sep 6, 2022 9:00 am EDT
Ocuphire Pharma to Present at The H.C. Wainwright 24th Annual Global Investment Conference
Sep 1, 2022 8:28 am EDT
Opus Genetics Hosts Inaugural Patient Advocacy Outreach Webinar on Inherited Retinal Diseases
Aug 12, 2022 7:00 am EDT
Ocuphire Pharma Announces Financial Results for the Second Quarter 2022 and Provides Corporate Update
Aug 8, 2022 7:00 am EDT
Ocuphire Pharma Announces Upcoming Presentations at Two Conferences in August
Aug 3, 2022 8:00 am EDT
Ocuphire Extends U.S. Patent Protection for Late-Stage Drug Candidate Nyxol® for Reversal of Mydriasis by Five More Years into 2039 with New Patent Issuance
Jul 21, 2022 8:00 am EDT
Opus Genetics Expands its Leadership Team
Jul 11, 2022 7:30 am EDT
Opus Genetics to Present at OIS Retina Innovation Summit 2022
Jul 7, 2022 8:00 am EDT
Ocuphire Announces Late-Breaking Paper for Nyxol for Reversal of Dilation Indication at Annual ASRS Meeting and Five More Presentations at Conferences in July
  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • Page 14
  • …
  • Page 19
  • Next Pagearrow_forward
rss_feed News RSS
  • location_cityCompany Profile
  • contact_pageContacts
  • rss_feedRSS News Feed
  • account_treeSitemap
©2025 Opus Genetics, Inc. All Rights Reserved.
  • Privacy Policy
  • Disclaimer
  • Sitemap
  • Accessibility Statement